Crystal Pharmatech Co., Ltd.
USPTO PatentsView assignee record - 23 granted patents across 8 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07B (General Methods OF Organic CHEMISTRY; Apparatus Therefor).
The verdict
According to USPTO PatentsView, Crystal ranks #12,887 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 8 technology areas.
- #12,887
- of 49,997 US assignees by volume
- 30th percentile
- by Innovation Score (29.2/100)
- 13.7
- avg claims per patent
- -85%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12887 · Foreign Corporation #12,887 · 23 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 23 grants
- MID-PACK #12,887/49,997
- PHOTO-FINISH Cadwell Laboratories
- CPC-NARROW C07B · 8 areas
- INNOV-THIN 29.2/100
- CLAIMS-RICH 13.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -85% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cadwell Laboratories, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Crystal’s 29.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Crystal
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Crystal Pharmatech · this assignee 29
Crystal Pharmatech · this assignee
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Crystal's Innovation Score is 29.2/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Crystal?
Each dot is one of Crystal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Crystal’s own 13.7 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Crystal's grants concentrate
Crystal Pharmatech Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 95.7% of grants classified under C07B (General Methods OF Organic CHEMISTRY; Apparatus Therefor). Peak complete grant year is 2019 (14 grants) versus a trough of 1 in 2017. By volume, Crystal sits between College DE France and Cardica, Inc..
Who files at Crystal's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- College DE France
College DE France
23 patents
- Consitex
Consitex S.A.
23 patents
- Cranial
Cranial Technologies, Inc.
23 patents
- Creighton Univers…
Creighton University
23 patents
- Ctera Networks
Ctera Networks Ltd.
23 patents
- Cadwell Laborator…
Cadwell Laboratories, Inc.
23 patents
- Cagent Vascular
Cagent Vascular, Inc.
23 patents
- Cardica
Cardica, Inc.
23 patents
- Crystal Pharmatech ◀
Crystal Pharmatech Co., Ltd.
23 patents
What this shows Crystal holds 23 patents at rank #12,867, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Crystal
By rank, the assignees closest to #12,867 in granted patent volume.
- College DE France #12,863 · 23 patents
- Consitex S.A. #12,864 · 23 patents
- Cranial Technologies, Inc. #12,865 · 23 patents
- Creighton University #12,866 · 23 patents
- Ctera Networks Ltd. #12,868 · 23 patents
- Cadwell Laboratories, Inc. #12,869 · 23 patents
- Cagent Vascular, Inc. #12,870 · 23 patents
- Cardica, Inc. #12,871 · 23 patents
Leaders in C07B (General Methods OF Organic Chemistry)
Other assignees with the most granted patents in Crystal's primary technology class.
Crystal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 30th percentile higher than 30% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 4.3% |
| 2018 | 5 | 21.7% |
| 2019 | 14 | 60.9% |
| 2020 | 3 | 13.0% |
Which technologies does Crystal Pharmatech Co., Ltd. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Crystal Pharmatech Co., Ltd.'s patent record in context - here's where to go next.
- Crystal Pharmatech Co., Ltd.'s lead technology class is C07B (General Methods OF Organic CHEMISTRY; Apparatus Therefor), 95.7% of its portfolio - see every assignee active in that class. Explore C07B
- Ranked #12,887 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Crystal Pharmatech Co., Ltd. against College DE France, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.